Category: Prescription Drugs
Prescription Drugs market research reports by Euromonitor International
-
Rx/Reimbursement Adult Incontinence in Switzerland
Rx/Reimbursement Adult Incontinence in Switzerland An ageing population in need of constant care is driving growth of Rx/reimbursement adult incontinence products in Switzerland among both elderly and temporary post-partum incontinence sufferers. Many Swiss consumers are visiting their doctors more ... Read More
-
Rx/Reimbursement Adult Incontinence in Germany
Rx/Reimbursement Adult Incontinence in Germany In 2023, rx/reimbursement adult incontinence in Germany continued to record positive value growth, particularly given the increased costs of products and the impact of a high inflation rate. Nevertheless, volume growth decreased marginally, in a similar ... Read More
-
Rx/Reimbursement Adult Incontinence in Serbia
Rx/Reimbursement Adult Incontinence in Serbia Volume sales of Rx/reimbursement adult incontinence in Serbia remained stable in 2023. The ageing population is the main driver of category sales, as the elderly tend to experience incontinence issues later in life. In tandem, rising inflation and the sq ... Read More
-
Rx/Reimbursement Adult Incontinence in Slovenia
Rx/Reimbursement Adult Incontinence in Slovenia The category of Rx/reimbursement adult incontinence experienced growth in both volume and value terms in 2023 in Slovenia, driven primarily by healthcare settings. As the elderly population continues to increase, more individuals are seeking treatment ... Read More
-
Rx/Reimbursement Adult Incontinence in Turkey
Rx/Reimbursement Adult Incontinence in Turkey The demand for Rx (prescription) adult incontinence products in Turkey experienced robust growth in 2023, driven by a surge in volume sales. Open-tape adult diapers designed for heavy incontinence dominated the market, with the Social Security Institutio ... Read More
-
Rx/Reimbursement Adult Incontinence in Israel
Rx/Reimbursement Adult Incontinence in Israel Rx/reimbursement adult incontinence saw growth in Israel in 2023. The National Insurance Institute of Israel encourages the elderly to remain at home in their communities. For this reason, it grants long-term care benefits to those who choose to stay at ... Read More
-
Rx/Reimbursement Adult Incontinence in Kazakhstan
Rx/Reimbursement Adult Incontinence in Kazakhstan An ageing population supported continued healthy value and volume growth of Rx/reimbursement adult incontinence in Kazakhstan in 2023. However, with the economy under strain, coupled with the consumer group expanding, the government is considering cu ... Read More
-
Rx/Reimbursement Adult Incontinence in Latvia
Rx/Reimbursement Adult Incontinence in Latvia The demographic landscape in Latvia is undergoing a significant shift, with an increasing proportion of the population comprising elderly individuals. This demographic trend is particularly pronounced among single pensioners who often require assistance, ... Read More
-
Rx/Reimbursement Adult Incontinence in Italy
Rx/Reimbursement Adult Incontinence in Italy Rx/reimbursement adult incontinence remained in a slump in Italy in 2023, as the government continues to reduce its spending in the healthcare system. In 2024, public expenditure in hospitals and so-called “Community Health Houses” will be further decreas ... Read More
-
Rx/Reimbursement Adult Incontinence in the Netherlands
Rx/Reimbursement Adult Incontinence in the Netherlands Value sales of RX/reimbursement adult incontinence products registered moderate growth in 2023. For many people who are embarrassed about incontinence issues, there is a preference to buy incontinence products online, despite insurance reimburse ... Read More
-
Rx/Reimbursement Adult Incontinence in Estonia
Rx/Reimbursement Adult Incontinence in Estonia In 2023, the demand for Rx/reimbursement adult incontinence witnessed continued growth in Estonia, with both value and volume experiencing an upward trajectory. This growth trend persisted despite the ongoing challenges associated with limited funding t ... Read More
-
Rx/Reimbursement Adult Incontinence in France
Rx/Reimbursement Adult Incontinence in France Rx/reimbursement adult incontinence in France continued its positive growth trend in 2023, in terms of both volume and current value sales, benefitting from the essential nature of the category’s products. There was a small deceleration in the first year ... Read More
-
Rx/Reimbursement Adult Incontinence in Colombia
Rx/Reimbursement Adult Incontinence in Colombia In 2023, incontinence Rx/Reimbursement recorded a rate that, although positive, has been the lowest since 2020. Even though these products are covered by MIPRES, a system in which physicians prescribe medicines, nutritional supplements, and diapers for ... Read More
-
Rx/Reimbursement Adult Incontinence in the US
Rx/Reimbursement Adult Incontinence in the US Rising consumer awareness around incontinence and proper condition management, partnerships with direct-to-consumer platforms and the expanding 65+ year-old population in the US all contributed to healthy value and volume growth in the Rx/reimbursement a ... Read More
-
Weight Loss Drugs and the Future of Weight Management and Wellbeing
Weight Loss Drugs and the Future of Weight Management and Wellbeing 2023 saw surging interest in weight loss driven by the rise of GLP-1 medications, with prescription drugs like Ozempic and Wegovy creating headlines during the year. Demand will continue to be strong in 2024, driven by the efficacy ... Read More
-
Rx/Reimbursement Adult Incontinence in Australia
Rx/Reimbursement Adult Incontinence in Australia The Continence Aids Payment Scheme Amendment (Eligibility) Instrument 2022 changed who can get payments under the Continence Aids Payment Scheme (CAPS) to avoid double-dipping. It means that care recipients who already receive continence products as p ... Read More
-
Rx/Reimbursement Adult Incontinence in Hong Kong, China
Rx/Reimbursement Adult Incontinence in Hong Kong, China In 2022, retail volume and value sales of rx/reimbursement adult incontinence remained insignificant in Hong Kong. The Comprehensive Social Security Assistance (CSSA) Scheme is primarily responsible for providing subsidies and reimbursements fo ... Read More
-
Haleon Plc in Consumer Health (World)
Haleon Plc in Consumer Health (World) After a successful demerger from GlaxoSmithKline Pc, Haleon Plc, formed in July 2022, continues to lead the consumer health industry, supported by its power brands. While North America is a key region, Asia Pacific, and the Middle East and Africa have provided s ... Read More
-
Pharmaceuticals and Medical Equipment in Asia Pacific
Pharmaceuticals and Medical Equipment in Asia Pacific In 2021, Asia Pacific ranked first globally in terms of production output of pharmaceuticals and medical equipment, with a turnover of USD857 billion. Over 2021-2030, the region is expected to record the fastest production growth globally, underp ... Read More
-
Rx/Reimbursement Adult Incontinence in Portugal
Rx/Reimbursement Adult Incontinence in Portugal PPI Euromonitor International's Rx/Reimbursement adult incontinence in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify t ... Read More
-
Rx/Reimbursement Adult Incontinence in Malaysia
Rx/Reimbursement Adult Incontinence in Malaysia There is no presence of Rx/reimbursement adult incontinence in Malaysia in 2021 and no indication that this will change in the forecast period. Euromonitor International's Rx/Reimbursement adult incontinence in Malaysia report offers a comprehensive g ... Read More
Research Assistance
